CN104066342A - 可用于改善年龄相关性疾病的组合物和方法 - Google Patents

可用于改善年龄相关性疾病的组合物和方法 Download PDF

Info

Publication number
CN104066342A
CN104066342A CN201280022679.3A CN201280022679A CN104066342A CN 104066342 A CN104066342 A CN 104066342A CN 201280022679 A CN201280022679 A CN 201280022679A CN 104066342 A CN104066342 A CN 104066342A
Authority
CN
China
Prior art keywords
composition
animal
approximately
enhancing
colostrum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280022679.3A
Other languages
English (en)
Chinese (zh)
Inventor
E·萨蒂亚拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN104066342A publication Critical patent/CN104066342A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
CN201280022679.3A 2011-03-18 2012-03-12 可用于改善年龄相关性疾病的组合物和方法 Pending CN104066342A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161465404P 2011-03-18 2011-03-18
US61/465,404 2011-03-18
PCT/US2012/028712 WO2012128982A2 (en) 2011-03-18 2012-03-12 Compositions and methods useful for ameliorating age related maladies

Publications (1)

Publication Number Publication Date
CN104066342A true CN104066342A (zh) 2014-09-24

Family

ID=46879965

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280022679.3A Pending CN104066342A (zh) 2011-03-18 2012-03-12 可用于改善年龄相关性疾病的组合物和方法

Country Status (12)

Country Link
US (1) US10010566B2 (enExample)
EP (1) EP2685987B1 (enExample)
JP (1) JP2014515011A (enExample)
CN (1) CN104066342A (enExample)
AU (1) AU2012231351B2 (enExample)
BR (1) BR112013023770B1 (enExample)
CA (1) CA2830476C (enExample)
ES (1) ES2727043T3 (enExample)
MX (1) MX359453B (enExample)
RU (1) RU2600893C2 (enExample)
WO (1) WO2012128982A2 (enExample)
ZA (1) ZA201307770B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109152749A (zh) * 2016-05-27 2019-01-04 雀巢产品技术援助有限公司 用于治疗或预防移动性受损的营养组合物
CN110801007A (zh) * 2019-12-17 2020-02-18 苟春虎 老年肌少症营养肽

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6648007B2 (ja) * 2013-06-13 2020-02-14 スマートフィッシュ・アーエス アルツハイマー病の治療、遅延及び／又は予防において使用するための、レスベラトロール又はその誘導体を含む水産油配合物
US8974832B1 (en) * 2013-12-10 2015-03-10 Lifewave, Inc. Nutritional product composition for increasing human growth hormone and nitric oxide production
WO2016092479A1 (en) * 2014-12-10 2016-06-16 Subramaniam Vanangamudi Sulur A pharmaceutical formulation comprising resveratrol, benfotiamine and pyridoxamine, a process of making it and a method of treatment using it
WO2016100826A1 (en) * 2014-12-19 2016-06-23 Avelis Llc Mineral complex formulations for oral administration and methods for their use
US10660683B2 (en) * 2016-05-27 2020-05-26 In2Bones Usa, Llc Method for sterile packaging of K-wire and cap
JPWO2018066394A1 (ja) * 2016-10-04 2019-10-03 日本水産株式会社 筋肉を柔軟にするための組成物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP7270546B2 (ja) * 2017-04-11 2023-05-10 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 個体における認知的加齢を特定及び軽減するためのオメガ３脂肪酸及びビタミンｄレベル
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
EP3853356A4 (en) 2018-09-20 2022-09-14 Mystem Biotechnologies Inc. STEM CELLS DERIVED FROM COLOSTRUM, NEURONAL DIFFERENTIATION, COMPOSITIONS AND SUPPLEMENTS FOR IMPROVING MAMMALIAN HEALTH
JP2021165235A (ja) * 2020-04-06 2021-10-14 株式会社ファンケル アトロジン−１発現抑制剤
MX2023002625A (es) * 2020-09-03 2023-03-17 Nestle Sa Composiciones y metodos para proporcionar beneficios para la salud en un animal.
US20250099515A1 (en) * 2021-12-09 2025-03-27 Societe Des Produits Nestle S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307478A (zh) * 1998-04-30 2001-08-08 诺思弗尔德实验室有限公司 食品组合物及其使用方法
US20060014773A1 (en) * 2001-04-19 2006-01-19 Mccleary Edward L Mental agility lozenge, edible strip, food or drink
CN101296693A (zh) * 2005-10-26 2008-10-29 花王株式会社 持久力提高剂
CN101360489A (zh) * 2005-12-23 2009-02-04 纽崔西亚公司 用于改善膜组成的包含多不饱和脂肪酸、蛋白质和锰和/或钼的组合物
CN101433241A (zh) * 2008-12-05 2009-05-20 江苏星驰生物科技有限公司 配方牛初乳
WO2010095926A1 (en) * 2009-02-20 2010-08-26 N.V. Nutricia Use of reveratrol for preserving cognitive functioning
CN101909632A (zh) * 2008-01-04 2010-12-08 雀巢产品技术援助有限公司 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
EP0862863B9 (en) 1997-01-09 2009-08-12 Societe Des Produits Nestle S.A. Cereal product containing probiotics
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
AU783678B2 (en) 1999-09-07 2005-11-24 Societe Des Produits Nestle S.A. Method for improving the skin and coat of pets
ID29913A (id) 1999-09-22 2001-10-25 Nestle Sa Metode peningkatan aktivitas hewan peliharaan
JP4343477B2 (ja) 2000-05-25 2009-10-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットフード用新規プロバイオチックス
WO2001091578A2 (en) 2000-05-26 2001-12-06 Societe Des Produits Nestle S.A. Foodstuff for pets or other animals
AU2002243267A1 (en) * 2000-10-27 2002-06-24 Mannatech, Inc. Dietary supplement compositions
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US20040166206A1 (en) 2003-02-25 2004-08-26 Archibald William E. Vacuum packaged food products and methods of making same
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
WO2007022991A1 (en) * 2005-08-26 2007-03-01 Nestec S.A. Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
PL2004201T3 (pl) 2006-03-29 2019-02-28 Nestec S.A. Suplementy diety zawierające probiotyki
JP2008189585A (ja) * 2007-02-02 2008-08-21 Qualicaps Co Ltd 水溶性硬質カプセル剤
JP2008214338A (ja) * 2007-02-08 2008-09-18 Shiseido Co Ltd 高次脳機能低下改善剤および遅延記憶低下改善剤
FR2913885B1 (fr) * 2007-03-22 2012-07-20 Univ Paris Descartes Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines
AU2008307494B2 (en) * 2007-10-04 2013-09-05 Société des Produits Nestlé S.A. Compositions and methods for enhancing cognitive function
US20100056484A1 (en) * 2008-08-26 2010-03-04 Scott Farese Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress
JP5606004B2 (ja) * 2009-03-31 2014-10-15 小林製薬株式会社 血中アルブミン量の増加促進または減少抑制用組成物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1307478A (zh) * 1998-04-30 2001-08-08 诺思弗尔德实验室有限公司 食品组合物及其使用方法
US20060014773A1 (en) * 2001-04-19 2006-01-19 Mccleary Edward L Mental agility lozenge, edible strip, food or drink
CN101296693A (zh) * 2005-10-26 2008-10-29 花王株式会社 持久力提高剂
CN101360489A (zh) * 2005-12-23 2009-02-04 纽崔西亚公司 用于改善膜组成的包含多不饱和脂肪酸、蛋白质和锰和/或钼的组合物
CN101909632A (zh) * 2008-01-04 2010-12-08 雀巢产品技术援助有限公司 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途
CN101433241A (zh) * 2008-12-05 2009-05-20 江苏星驰生物科技有限公司 配方牛初乳
WO2010095926A1 (en) * 2009-02-20 2010-08-26 N.V. Nutricia Use of reveratrol for preserving cognitive functioning

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张璨文，等: "硫辛酸抗氧化性及其生理保健功能研究进展", 《科技通报》 *
高根德，等: "《康复疗法学》", 31 December 2008, 上海科学技术出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109152749A (zh) * 2016-05-27 2019-01-04 雀巢产品技术援助有限公司 用于治疗或预防移动性受损的营养组合物
CN110801007A (zh) * 2019-12-17 2020-02-18 苟春虎 老年肌少症营养肽

Also Published As

Publication number Publication date
MX359453B (es) 2018-09-28
WO2012128982A3 (en) 2014-04-24
CA2830476A1 (en) 2012-09-27
US10010566B2 (en) 2018-07-03
AU2012231351A1 (en) 2013-09-26
BR112013023770B1 (pt) 2020-12-15
WO2012128982A2 (en) 2012-09-27
ES2727043T3 (es) 2019-10-11
RU2600893C2 (ru) 2016-10-27
MX2013010680A (es) 2013-10-03
AU2012231351B2 (en) 2016-03-10
EP2685987A2 (en) 2014-01-22
CA2830476C (en) 2019-09-24
EP2685987A4 (en) 2014-08-20
ZA201307770B (en) 2015-04-29
US20140004205A1 (en) 2014-01-02
JP2014515011A (ja) 2014-06-26
EP2685987B1 (en) 2019-04-24
RU2013146517A (ru) 2015-04-27
BR112013023770A2 (pt) 2016-12-06

Similar Documents

Publication Publication Date Title
US10010566B2 (en) Compositions and methods useful for ameliorating age related maladies
JP6301655B2 (ja) 健康な皮膚の促進に適した方法及び組成物
CN101820754A (zh) 用于增强认知功能的组合物与方法
CN101909632A (zh) 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途
WO2012087742A2 (en) Methods and compositions suitable for managing blood glucose in animals
AU2012218094A1 (en) Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals
CN106998748A (zh) 用于治疗癫痫的包含中链甘油三酯的组合物和方法
EP2654744A1 (en) Methods and compositions for preventing and treating osteoarthritis
EP2706849A1 (en) Methods and compositions for promoting lean body mass growth
WO2013052433A2 (en) Methods and compositions for reducing food intake and body weight gain in animals
CA2835439A1 (en) Methods and compositions for preserving lean body mass during weight loss

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140924

RJ01 Rejection of invention patent application after publication